142 related articles for article (PubMed ID: 8349438)
41. Endostar combined with chemotherapy for treatment of metastatic colorectal and gastric cancer: a pilot study.
Zhou JF; Bai CM; Wang YZ; Li XY; Cheng YJ; Chen SC
Chin Med J (Engl); 2011 Dec; 124(24):4299-303. PubMed ID: 22340403
[TBL] [Abstract][Full Text] [Related]
42. Phase II trial of UFT in advanced colorectal and gastric cancer.
Malik ST; Talbot D; Clarke PI; Osborne R; Reznek R; Wrigley PF; Slevin ML
Br J Cancer; 1990 Dec; 62(6):1023-5. PubMed ID: 2257207
[TBL] [Abstract][Full Text] [Related]
43. A randomized phase I and II study of short-term infusion of high-dose fluorouracil with or without N-(phosphonacetyl)-L-aspartic acid in patients with advanced pancreatic and colorectal cancers.
Ardalan B; Singh G; Silberman H
J Clin Oncol; 1988 Jun; 6(6):1053-8. PubMed ID: 3373260
[TBL] [Abstract][Full Text] [Related]
44. Treatment of patients with upper gastrointestinal carcinomas.
Ajani JA
Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-72-S19-76. PubMed ID: 9427271
[TBL] [Abstract][Full Text] [Related]
45. Phase II clinical trial of parenteral hydroxyurea in combination with fluorouracil, interferon and filgrastim in the treatment of advanced pancreatic, gastric and neuroendocrine tumors.
Kaubisch A; Kaleya R; Haynes H; Rozenblit A; Wadler S
Cancer Chemother Pharmacol; 2004 Apr; 53(4):337-40. PubMed ID: 14704829
[TBL] [Abstract][Full Text] [Related]
46. Phase II study of pyrazoloacridine in patients with advanced colorectal carcinoma.
Zalupski MM; Philip PA; LoRusso P; Shields AF
Cancer Chemother Pharmacol; 1997; 40(3):225-7. PubMed ID: 9219505
[TBL] [Abstract][Full Text] [Related]
47. Phase I clinical and pharmacokinetic/pharmacogenetic study of a triplet regimen of S-1/irinotecan/oxaliplatin in patients with metastatic colorectal or gastric cancer.
Park SR; Hong YS; Lim HS; Seong MW; Kong SY; Kim SY; Park YI; Jung KH
Cancer Chemother Pharmacol; 2013 Nov; 72(5):953-64. PubMed ID: 23982118
[TBL] [Abstract][Full Text] [Related]
48. Role of chemotherapy in the palliation of gastrointestinal malignancies.
Pelley RJ
Semin Oncol; 1995 Apr; 22(2 Suppl 3):45-52. PubMed ID: 7537904
[TBL] [Abstract][Full Text] [Related]
49. Carzelesin phase II study in advanced breast, ovarian, colorectal, gastric, head and neck cancer, non-Hodgkin's lymphoma and malignant melanoma: a study of the EORTC early clinical studies group (ECSG).
Pavlidis N; Aamdal S; Awada A; Calvert H; Fumoleau P; Sorio R; Punt C; Verweij J; van Oosterom A; Morant R; Wanders J; Hanauske AR
Cancer Chemother Pharmacol; 2000; 46(2):167-71. PubMed ID: 10972487
[TBL] [Abstract][Full Text] [Related]
50. Antitumor activity of brequinar sodium (Dup-785) against human head and neck squamous cell carcinoma xenografts.
Braakhuis BJ; van Dongen GA; Peters GJ; van Walsum M; Snow GB
Cancer Lett; 1990 Feb; 49(2):133-7. PubMed ID: 2306706
[TBL] [Abstract][Full Text] [Related]
51. Pilot study of enhancement of cisplatin activity by high dose cytarabine in advanced gastric and colorectal (G3/G4) cancer.
Popov I; Jelić S; Radulović S; Tomasević Z
Neoplasma; 1996; 43(4):221-4. PubMed ID: 8931744
[TBL] [Abstract][Full Text] [Related]
52. A phase II trial of piroxantrone in adenocarcinoma of the pancreas. A Southwest Oncology Group study.
Jenkins TR; Tangen C; Macdonald JS; Weiss G; Chapman R; Hantel A
Invest New Drugs; 1993 Nov; 11(4):329-31. PubMed ID: 8157474
[TBL] [Abstract][Full Text] [Related]
53. Clinical strategies in the chemotherapy of gastrointestinal cancer.
Macdonald JS; Woolley PV; Schein PS
Recent Results Cancer Res; 1980; 70():179-85. PubMed ID: 6986641
[TBL] [Abstract][Full Text] [Related]
54. A phase II clinical trial of diaziquone (AZQ) in the treatment of patients with recurrent adenocarcinoma and adenosquamous carcinoma of the cervix. A Gynecologic Oncology Group study.
Slayton RE; Blessing JA; Rettenmaier M; Ball H
Invest New Drugs; 1989 Nov; 7(4):337-40. PubMed ID: 2599803
[TBL] [Abstract][Full Text] [Related]
55. Chemotherapy of advanced gastrointestinal cancer.
Geoffroy F; Grem JL
Curr Opin Oncol; 1994 Jul; 6(4):427-34. PubMed ID: 7803544
[TBL] [Abstract][Full Text] [Related]
56. A phase 1 and dose-finding study of LY2523355 (litronesib), an Eg5 inhibitor, in Japanese patients with advanced solid tumors.
Wakui H; Yamamoto N; Kitazono S; Mizugaki H; Nakamichi S; Fujiwara Y; Nokihara H; Yamada Y; Suzuki K; Kanda H; Akinaga S; Tamura T
Cancer Chemother Pharmacol; 2014 Jul; 74(1):15-23. PubMed ID: 24752449
[TBL] [Abstract][Full Text] [Related]
57. Paclitaxel in the treatment of patients with upper gastrointestinal carcinomas.
Ajani JA; Ilson DH; Kelsen DP
Semin Oncol; 1996 Oct; 23(5 Suppl 12):55-8. PubMed ID: 8941411
[TBL] [Abstract][Full Text] [Related]
58. Combination chemotherapy with cisplatin, carboplatin, and etoposide in advanced malignancy: a phase I trial.
Rajkumar SV; Frytak S; Rubin J; Camoriano JK; Fitch TR
Am J Clin Oncol; 1997 Oct; 20(5):500-4. PubMed ID: 9345336
[TBL] [Abstract][Full Text] [Related]
59. Phase II study of weekly paclitaxel plus 24-h continuous infusion 5-fluorouracil, folinic acid and 3-weekly cisplatin for the treatment of patients with advanced gastric cancer.
Honecker F; Kollmannsberger C; Quietzsch D; Haag C; Schroeder M; Spott C; Hartmann JT; Baronius W; Hempel V; Kanz L; Bokemeyer C
Anticancer Drugs; 2002 Jun; 13(5):497-503. PubMed ID: 12045461
[TBL] [Abstract][Full Text] [Related]
60. [Cetuximab in combination with chemotherapy for patients with gastrointestinal cancer].
Zhang XT; Shen L; Zhang XD; Li J; Zhang ZT
Zhonghua Zhong Liu Za Zhi; 2008 May; 30(5):385-8. PubMed ID: 18953842
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
